Oral IL-23 Inhibitor Calms Moderate to Severe Psoriasis Oral IL-23 Inhibitor Calms Moderate to Severe Psoriasis

The small-molecule oral investigational agent JNJ-77242113 at the highest dose tested was associated with reductions in psoriasis severity comparable to injectable biologic agents.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Source Type: news